CLINICAL_TRIALS
trial_result
· 2025-06-05
Clinical Trial Update: Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer [Phase 3]
Summary
Phase 3 trial evaluating triptorelin in combination with radiation therapy after surgery for intermediate-risk stage III or stage IV prostate cancer has complet…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UNICANCER | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED